Health Trials

Immune Complex Membranoproliferative Glomerulonephritis

1

Review clinical trials related to Immune Complex Membranoproliferative Glomerulonephritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

This is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan in subjects with C3 glomerulopathy or idiopathic immune-complex-membranoproliferative glomerulonephritis

Participants needed: 225
Trial details
Phase: Phase 3Age: 12-100Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: Apr 14, 2026Locations: 50
Eligibility criteria

Severe concurrent co-morbidities, e.g. advanced cardiac disease (NYHA class IV),... [+3]

Read more